Toggle navigation
Home
Trading Services
All Trading Services
Most Popular Services
Elite Trader
Quick-Hit Trader
Champion Trader
Ultimate Trader
View All
Directional Trading Alerts
Options Under $5
Leverage
Weekly Options Trader
Event Trader
PowerTrend
Schaeffer's Players
Overnight Trader
View All
Advanced Trading Alerts
Wealthbuilder
Premium Trader
Hedge Hunter
Volatility Trader
Weekly Volatility Trader
View All
Weekend Alert Services
Weekend Player
Weekend Trader Alert
Expiration Week Countdown
Weekly Options Countdown
View All
Newsletter Trading Services
Master Portfolio
The Option Advisor
Schaeffer's Daily Bulletin
View All
Courses & Education
Getting Started with Options
View All
Market News
Sign Up for Free Market Newsletters
Opening View
Midday Market Check
Market Recap
View All Free Subscriptions
Featured Publications
From the Top
Monday Morning Outlook
Indicator of the Week
Editor's Picks
View All
Trading Analysis
Best & Worst Stocks
Earnings Preview
Investor Sentiment
Quantitative Analysis
Technical Analysis
VIX & Volatility
View All
Stock Options
Intraday Options Activity
Most Active Options
Trade Postmortems
Options Recommendations
View All
Trading Education
Strategies & Concepts
Expectational Analysis
View All
Market News
Buzz Stocks
Stocks on the Move
Analyst Update
5 Minute Market Rundown
Stock Market Podcasts
View All
Daily Market Newsletters
Opening View
Midday Market Check
Market Recap
View All
Education
Offers
Free Trial
Broker Center
Current Promotions
About
About Schaeffer's Research
Legal Notices
Search
My Account
Contact Us
content-search-index
Tag: AXGT
AXGT
4
SEARCH RESULTS FOR: "Tag: AXGT"
REFINE YOUR SEARCH
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019
(4)
CATEGORIES
Analyst Update
(3)
Buzz Stocks
(1)
Intraday Option Activity
(1)
Baird: Buy This Biotech Before Data Release
https://www.schaeffersresearch.com/content/news/2019/08/12/baird-buy-this-biotech-before-data-release
8/12/2019 2:59 PM
Axovant Gene Therapies Ltd (NASDAQ:AXGT) is getting a boost from Baird today -- bucking the broad-market trend lower -- after the analyst upgraded the biotech to "outperform" from "neutral," predicti...
Options Heat Up on "Undervalued" Drug Stock
https://www.schaeffersresearch.com/content/options/2019/06/21/options-heat-up-on-undervalued-drug-stock
6/21/2019 10:34 AM
The shares of Axovant Gene Therapies Ltd (NASDAQ:AXGT) are soaring today, thanks to some upbeat analyst attention. Specifically, SVB Leerink initiated coverage of AXGT stock with an "outperform" rati...
Jefferies Calls Bottom on Gene Therapy Stock After Huge Sell-Off
https://www.schaeffersresearch.com/content/news/2019/06/12/jefferies-calls-bottom-on-gene-therapy-stock-after-huge-sell-off
6/12/2019 10:30 AM
Axovant Sciences Ltd (NASDAQ:AXGT) has seen its stock fall from the mid-$30 range to yesterday's close of $3.94, even after positive data for its Parkinson's treatment. However, Jefferies referred to...
Penny Stock Pops on Parkinson's Treatment Progress
https://www.schaeffersresearch.com/content/news/2019/03/11/penny-stock-pops-on-parkinsons-treatment-progress
3/11/2019 9:43 AM
The shares of biotechnology concern Axovant Sciences Ltd (NASDAQ:AXGT) are up 54% at $2.28 in early trading after announcing successful phase 2 trial results for its Parkinson's treatment, AXO-Lenti...
LOAD MORE
PEOPLE ALSO SEARCH FOR
AXGT
Partner Center